Viewing Study NCT04973904


Ignite Creation Date: 2025-12-24 @ 7:58 PM
Ignite Modification Date: 2025-12-31 @ 8:44 AM
Study NCT ID: NCT04973904
Status: UNKNOWN
Last Update Posted: 2021-07-22
First Post: 2021-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer
Sponsor: Peking Union Medical College Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module